Profile data is unavailable for this security.
About the company
APT Medical Inc is a China-based company mainly engaged in the research and development, manufacture and sales of electrophysiological and vascular interventional medical devices. The Company's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The Company's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The Company is also engaged in related original equipment manufacturer (OEM) business. The Company distributes its products within domestic market and to overseas markets.
- Revenue in CNY (TTM)1.96bn
- Net income in CNY658.82m
- Incorporated2002
- Employees2.16k
- LocationAPT Medical Inc601, Building B, Tongfang InformationLangshan Road, Songpingshan, SongpingshaSHENZHEN 518000ChinaCHN
- Phone+86 75 586951506
- Fax+86 75 526030108
- Websitehttps://www.aptmed.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MGI Tech Co Ltd | 2.58bn | -873.08m | 20.75bn | 2.87k | -- | 2.59 | -- | 8.05 | -2.12 | -2.12 | 6.26 | 19.21 | 0.2467 | 0.7745 | 2.87 | 898,663.20 | -8.40 | -- | -9.62 | -- | 59.99 | -- | -34.04 | -- | 3.99 | -- | 0.0766 | -- | -31.19 | -- | -129.98 | -- | -- | -- |
| Autobio Diagnostics Co Ltd | 4.58bn | 1.27bn | 27.33bn | 5.54k | 21.44 | 3.25 | -- | 5.97 | 2.19 | 2.19 | 7.90 | 14.46 | 0.4079 | 1.91 | 3.93 | 827,079.50 | 11.38 | 12.59 | 14.54 | 15.79 | 64.93 | 61.62 | 27.90 | 26.96 | 2.18 | -- | 0.1093 | 46.40 | 0.0457 | 18.15 | 4.28 | 16.70 | 17.03 | 11.32 |
| APT Medical Inc | 1.96bn | 658.82m | 36.29bn | 2.16k | 55.07 | 15.18 | -- | 18.50 | 6.77 | 6.77 | 20.14 | 24.54 | 0.7475 | 1.49 | 36.01 | 910,130.40 | 24.68 | 18.12 | 30.71 | 21.94 | 71.13 | 70.30 | 33.02 | 27.07 | 3.05 | -- | 0.0051 | 26.49 | 35.71 | 46.83 | 49.13 | 90.09 | 44.39 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 4.36m | 4.48% |
| China Asset Management Co., Ltd.as of 30 Sep 2024 | 4.06m | 4.18% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 3.76m | 3.87% |
| E Fund Management Co., Ltd.as of 30 Sep 2024 | 3.39m | 3.49% |
| Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 2024 | 2.19m | 2.25% |
| Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2024 | 2.17m | 2.23% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 2.03m | 2.09% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 1.67m | 1.72% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 1.33m | 1.36% |
| Bosera Asset Management Co., Ltd.as of 07 Nov 2024 | 1.03m | 1.06% |
